# Aprea Therapeutics, Inc.: Form DEF 14A, filed Apr 22, 2025

- Company: [Aprea Therapeutics, Inc.](/companies/apre.md) (CIK 1781983)
- Form: DEF 14A
- Filed: 2025-04-22
- Accepted by EDGAR: Apr 22, 2025, 16:05 ET
- Period: 2025-06-05
- Accession: 0001558370-25-005141
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1781983/000155837025005141/apre-20250605xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781983/000155837025005141/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781983/000155837025005141/apre-20250605xdef14a.htm

Filed Apr 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-005141. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.